ResearcherFudan UniversityNo recent work listed
Yan Sun
Known by name at one institution; no external author ID yet. Name as it appears in OpenAlex.
Their work
- Papers
- 4 (first author 4, last author 0)
- Trials
- 0
- Grants
- 0
- Collaborators
- 3
2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper
Papers 4
- Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer. First author DOI 10.1186/s13046-018-0818-z↗
- Role of transgelin-2 in diabetes-associated pancreatic ductal adenocarcinoma. First author DOI 10.18632/oncotarget.17519↗
- SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism. First author DOI 10.1007/s13277-015-3047-5↗
- Connexin 43 interacts with Bax to regulate apoptosis of pancreatic cancer through a gap junction-independent pathway. First author DOI 10.3892/ijo.2012.1524↗
Closest collaborators
The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Yu Hu · 4 shared papers, 2012–2018
- Paper Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer. DOI 10.1186/s13046-018-0818-z↗
- Paper Role of transgelin-2 in diabetes-associated pancreatic ductal adenocarcinoma. DOI 10.18632/oncotarget.17519↗
- Paper SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism. DOI 10.1007/s13277-015-3047-5↗
- Yuhong Zhou · 2 shared papers, 2015–2017
- Yaozong Yuan · 1 shared paper, 2012
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.